Embed Size (px)
Citation preview
RESEARCH • COLLABORAT ION • ADVANCEMENT
Cambridge Innovation InstituteCHI is a division of
Conference, Short Course, and Training Seminar CatalogSeptember 2019 – February 2020
Cambridge
HEALTHTECHInstitute
Cambridge
HEALTHTECHInstitute
Cambridge
HEALTHTECHInstitute
Your Life Science Netw
ork
Cam
brid
ge HEALTHTECH Institute
Your Life Science Netw
ork
Cam
brid
ge HEALTHTECH Institute
Your Life Science Network
2 | Cambridge Healthtech Institute
For over 25 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation.
Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business.
For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com.
About Cambridge Healthtech Institute
Follow us
TABLE OF CONTENTS
CONFERENCE SERIESBiological Therapeutic Products ...................................................... 4BioPharmaceutical Strategy ............................................................ 4Biomarkers and Diagnostics ........................................................... 5Bioprocess and Manufacturing ....................................................... 5Chemistry ....................................................................................... 5Healthcare ....................................................................................... 5Clinical Trials & Translational Medicine ............................................ 6Drug Targets .................................................................................... 6Drug Discovery & Development ..................................................... 7Detection ........................................................................................ 7Therapeutic Indications ................................................................... 7Genomics ........................................................................................ 8Informatics and IT ........................................................................... 8Technology and Tools for Life Sciences ........................................... 8
CONFERENCES BY DATE WITH DETAIL .......................................... 9
SHORT COURSES AND TRAINING SEMINARS .............................11
CLIENT RELATIONSPamela GerardiDirector, Client RelationsE: [email protected] | T: 781-972-5409
Kris WatermanClient Relations ManagerE: [email protected] | T: 781-972-5413
Rose LaRaiaOffice Manager & Client RelationsE: [email protected] | T: 781-972-5400
MARKETINGJim MacNeilVice President of MarketingE: [email protected] | T: 781-972-5441
Rich HandySenior Director of MarketingE: [email protected] | T: 781-972-5456
SPONSOR & EXHIBIT SALESAngela ParsonsVice President of Business DevelopmentE: [email protected] | T: 781-972-5467
Joseph Vacca, M.S.,Director, Business DevelopmentE: [email protected] | T: 781-972-5431
GROUP SALES David CunninghamDirector, Inside SalesE: [email protected] | T: 781-972-5472
GRAPHICSThomas NortonDesign DirectorE: [email protected] | T: 781-972-5440
PRODUCTIONEdel O’ Regan, Ph.D.Vice President of ProductionE: [email protected] | T: 781-972-5423
Christina LinghamExecutive Director, Conferences and FellowE: [email protected] | T: 781-972-5464
Mary Ann BrownExecutive Director of ConferencesE: [email protected] | T: 781-972-5497
Julia Boguslavsky Executive Director of ConferencesE: [email protected] | T: 760-732-3139
Micah LiebermanExecutive Director of ConferencesE: [email protected] | T: 541-482-4709
Marina FilshtinskyExecutive Director of ConferencesE: [email protected] | T: 781-97205496
CONTACT US
@CHI_Healthtech
LinkedIn.com/company/Cambridge-Healthtech-Institute
Facebook.com/HealthtechConferences
YouTube.com/user/CambridgeHealthtech
Cambridge Healthtech Institute 250 First Avenue, Suite 300 | Needham, MA 02494
T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288
F: (781) 972-5425
September 2019 – February 2020 | 3 www.healthtech.com
2019–2020 KEY EVENTS
September 16-19, 2019Westin Copley Place
Boston, MA
DiscoveryOnTarget.com
Protein & Antibody Engineering Summit
November 18-22, 2019Lisbon Congress Center
Lisbon, Portugal
PEGSummitEurope.com
THE PROTEIN SCIENCE WEEK
January 20-24, 2020Hilton San Diego Bayfront
San Diego, CA
CHI-PepTalk.com
SUMMIT FOR CLINICAL OPS EXECUTIVES
February 18-21, 2020Hyatt Regency Orlando
Orlando, FL
SCOPESummit.com
March 1-4, 2020Moscone South Convention Ctr
San Francisco, CA
Triconference.com
Drug DiscoveryChemistry
April 13-17, 2020Hilton San Diego Bayfront
San Diego, CA
Drugdiscoverychemistry.com
April 21-23, 2020Seaport World Trade Center
Boston, MA
Bio-itworldexpo.com
May 4-8, 2020Seaport World Trade Center
Boston, MA
Pegsummit.com
WORLD PHARMA WEEK
June 1-4, 2020Hynes Convention Center
Boston, MA
PharmaWeek.com
Clinical Trials to the Clinic
CLINICALRESEARCHNEWSClinicalResearchNewsOnline.com
Diagnostics WorldBeyond the Odyssey: Emerging Technologies in Diagnostics
DiagnosticsWorldNews.com
DAILY AND BREAKING NEWS • COMPLIMENTARY NEWSLETTERS AND eBOOKS • Free Industry Whitepapers, Podcasts, Market Survey Results, Webinars • Online Product Directory
Bio-ITWorld.com
SUBSCRIBE TODAY
Immuno OncologySUMMI T
7TH ANNUAL
August 10-14, 2020Westin Copley Place
Boston, MA
Immuno-OncologySummit.com
August 24-28, 2020Hynes Convention Center
Boston, MA
BioprocessingSummit.com
August 25-27, 2020Grand Hyatt Washington
Washington, DC
NextGenerationDX.com
4 | Cambridge Healthtech Institute
Conferences by Series
Biological Therapeutic Products
Immuno-Oncology: Emerging Targets and TherapeuticsSeptember 17-18 • Boston, MAAntibodies Against Membrane Protein Targets – Part 1September 17-18 • Boston, MATargeting NASHSeptember 17-18 • Boston, MAAntibody Forum – Part 1September 17-18 • Boston, MARNA as a Drug TargetSeptember 18-19 • Boston, MATargeting FibrosisSeptember 18-19 • Boston, MAAntibody Forum – Part 2September 18-19 • Boston, MAAntibodies Against Membrane Protein Targets – Part 2September 18-19 • Boston, MAImmunogenicity & Bioassay SummitOctober 15-18 • Alexandria, VASYMPOSIUM: Immunology for BiotherapeuticsOctober 15 • Alexandria, VAImmunogenicity Assessment & Clinical RelevanceOctober 16-17 • Alexandria, VAImmunogenicity Prediction & ControlOctober 17-18 • Alexandria, VAOptimizing Bioassays for BiologicsOctober 17-18 • Alexandria, VAPEGS Europe: Protein & Antibody Engineering SummitNovember 18-22 • Lisbon, PortugalModulating the Tumour MicroenvironmentNovember 18-19 • Lisbon, Portugal
Optimisation & DevelopabilityNovember 18-19 • Lisbon, PortugalDisplay of BiologicsNovember 18-19 • Lisbon, PortugalNext-Generation Antibody-Drug ConjugatesNovember 18-19 • Lisbon, PortugalCell Line and Systems EngineeringNovember 18-19 • Lisbon, PortugalOptimising Expression PlatformsNovember 20-21 • Lisbon, PortugalAnalytical Characterisation of BiotherapeuticsNovember 20-21 • Lisbon, PortugalEngineering AntibodiesNovember 20-21 • Lisbon, PortugalWinning Strategies for CAR T, TIL and TCR TherapyNovember 20-21 • Lisbon, PortugalEngineering BispecificsNovember 21-22 • Lisbon, PortugalNovel Targets for Cancer and Emerging Therapeutic AreasNovember 21-22 • Lisbon, PortugalProtein Aggregation & StabilityNovember 21-22 • Lisbon, PortugalAgonist Immunotherapy TargetsNovember 21-22 • Lisbon, PortugalPepTalk- The Protein Science WeekJanuary 20-24 • San Diego, CAEngineering Next-Generation Cancer ImmunotherapiesJanuary 20-21 • San Diego, CARecombinant Protein TherapeuticsJanuary 20-21 • San Diego, CAEngineering Genes, Vectors, Constructs, and ClonesJanuary 20-21 • San Diego, CA
Vector Design and Development for Gene and Cell TherapiesJanuary 20-21 • San Diego, CACharacterization of BiotherapeuticsJanuary 20-21 • San Diego, CABioprocess Data Management and AnalysisJanuary 20-21 • San Diego, CALyophilization and Emerging Drying TechnologiesJanuary 21-22 • San Diego, CAProtein Purification & RecoveryJanuary 21-22 • San Diego, CAAntibody-Drug ConjugatesJanuary 21-22 • San Diego, CARecombinant Protein Expression and ProductionJanuary 21-22 • San Diego, CAGene Therapy Analytics and ManufacturingJanuary 21-22 • San Diego, CADetection and Characterization of Particulates and ImpuritiesJanuary 21-22 • San Diego, CAHigher-Throughput Protein Production & CharacterizationJanuary 23-24 • San Diego, CAProtein Aggregation and Emerging Analytical ToolsJanuary 23-24 • San Diego, CABispecific Antibody TherapeuticsJanuary 23-24 • San Diego, CAOptimizing Expression PlatformsJanuary 23-24 • San Diego, CACell Therapy Analytics and ManufacturingJanuary 23-24 • San Diego, CA
Summit for Clinical Ops Executives EuropeSeptember 17-19 • Barcelona, SpainExecutive Decision MakingOctober 14-18 • Philadelphia, PAStrategic and Operational Challenges of Oncology and Immuno-Oncology Drug DevelopmentOctober 14-15 • Philadelphia, PADecision Analysis & Portfolio Management for Biopharma Master ClassOctober 14-15 • Philadelphia, PAStrategic Resource ManagementOctober 16-17 • Philadelphia, PAPortfolio ManagementOctober 17-18 • Philadelphia, PA
Optimisation & DevelopabilityNovember 18-19 • Lisbon, PortugalEngineering AntibodiesNovember 20-21 • Lisbon, PortugalAgonist Immunotherapy TargetsNovember 21-22 • Lisbon, PortugalEngineering Genes, Vectors, Constructs, and ClonesJanuary 20-21 • San Diego, CABioprocess Data Management and AnalysisJanuary 20-21 • San Diego, CARecombinant Protein Expression and ProductionJanuary 21-22 • San Diego, CA
Lead and Candidate Selection for Therapeutic ProteinsJanuary 21-22 • San Diego, CAOptimizing Expression PlatformsJanuary 23-24 • San Diego, CASummit for Clinical Ops Executives (SCOPE)February 18-21 • Orlando, FLMastering an Outsourcing StrategyFebruary 19-20 • Orlando, FLManaging Outsourced Clinical TrialsFebruary 20-21 • Orlando, FL
September 2019 – February 2020 | 5 www.healthtech.com
Conferences by Series
Summit for Clinical Ops Executives EuropeSeptember 17-19 • Barcelona, SpainSensors for Medical Device and Implantable ApplicationsDecember 10-11 • San Diego, CA
Sensor R&D for Healthcare ApplicationsDecember 12 • San Diego, CAAccessing and Generating RWDFebruary 19-20 • Orlando, FL
Patient Engagement, Enrollment and Retention through Communities and TechnologyFebruary 20-21 • Orlando, FLLeveraging RWD for Clinical and Observational ResearchFebruary 20-21 • Orlando, FL
Targeting NASHSeptember 17-18 • Boston, MATargeting FibrosisSeptember 18-19 • Boston, MALeaders in Biobanking CongressOctober 30 - November 1 • Miami, FL
Sensors for Medical Device and Implantable ApplicationsDecember 10-11 • San Diego, CASensor R&D for Healthcare ApplicationsDecember 12 • San Diego, CAClinical Biomarkers Operations and InnovationFebruary 19-20 • Orlando, FL
Sensors, Wearables and Digital Biomarkers in Clinical TrialsFebruary 19-20 • Orlando, FLClinical Biospecimens Technology and OutsourcingFebruary 20-21 • Orlando, FL
Antibodies Against Membrane Protein Targets – Part 1September 17-18 • Boston, MAAntibodies Against Membrane Protein Targets – Part 2September 18-19 • Boston, MAOptimizing Bioassays for BiologicsOctober 17-18 • Alexandria, VACell Line and Systems EngineeringNovember 18-19 • Lisbon, PortugalOptimising Expression PlatformsNovember 20-21 • Lisbon, PortugalProtein Aggregation & StabilityNovember 21-22 • Lisbon, PortugalProtein Purification TechnologiesNovember 21-22 • Lisbon, PortugalMaterials, Design & Engineering for Sensor ManufacturingDecember 10-11 • San Diego, CAMEMs Enabled Smart Sensor ManufacturingDecember 12 • San Diego, CA
PepTalk- The Protein Science WeekJanuary 20-24 • San Diego, CAOptimizing Biologics Formulation DevelopmentJanuary 20-21 • San Diego, CAEngineering Genes, Vectors, Constructs, and ClonesJanuary 20-21 • San Diego, CAVector Design and Development for Gene and Cell TherapiesJanuary 20-21 • San Diego, CACharacterization of BiotherapeuticsJanuary 20-21 • San Diego, CABioprocess Data Management and AnalysisJanuary 20-21 • San Diego, CALyophilization and Emerging Drying TechnologiesJanuary 21-22 • San Diego, CAProtein Purification & RecoveryJanuary 21-22 • San Diego, CARecombinant Protein Expression and ProductionJanuary 21-22 • San Diego, CA
Lead and Candidate Selection for Therapeutic ProteinsJanuary 21-22 • San Diego, CAGene Therapy Analytics and ManufacturingJanuary 21-22 • San Diego, CADetection and Characterization of Particulates and ImpuritiesJanuary 21-22 • San Diego, CAHigher-Throughput Protein Production & CharacterizationJanuary 23-24 • San Diego, CAProtein Aggregation and Emerging Analytical ToolsJanuary 23-24 • San Diego, CAOptimizing Expression PlatformsJanuary 23-24 • San Diego, CADeep Sequencing and Single Cell Analysis for Antibody DiscoveryJanuary 23-24 • San Diego, CACell Therapy Analytics and ManufacturingJanuary 23-24 • San Diego, CA
Emerging Ubiquitin and Autophagy TargetsSeptember 17-18 • Boston, MAImmuno-Oncology: Emerging Targets and TherapeuticsSeptember 17-18 • Boston, MALead Generation StrategiesSeptember 17-18 • Boston, MA
Targeting NASHSeptember 17-18 • Boston, MAKinase Inhibitor DiscoverySeptember 17-18 • Boston, MAPROTACs and Targeted Protein DegradationSeptember 18-19 • Boston, MATargeting FibrosisSeptember 18-19 • Boston, MA
GPCR-Based Drug DiscoverySeptember 18-19 • Boston, MALeveraging RWD for Clinical and Observational ResearchFebruary 20-21 • Orlando, FLClinical Biospecimens Technology and OutsourcingFebruary 20-21 • Orlando, FL
6 | Cambridge Healthtech Institute
Conferences by Series
Immuno-Oncology: Emerging Targets and TherapeuticsSeptember 17-18 • Boston, MATargeting NASHSeptember 17-18 • Boston, MATargeting FibrosisSeptember 18-19 • Boston, MASummit for Clinical Ops Executives EuropeSeptember 17-19 • Barcelona, SpainAnalytics-Driven Feasibility, Site Selection and Study ActivationSeptember 17-18 • Barcelona, SpainPatient-Centric Enrollment Planning and EngagementSeptember 17-18 • Barcelona, SpainRisk-Based Monitoring EuropeSeptember 17-18 • Barcelona, SpainDigitalization of Clinical TrialsSeptember 17-18 • Barcelona, SpainBudgeting, Resource Management, and Outsourcing for Clinical TrialsSeptember 17-18 • Barcelona, SpainExecutive Decision MakingOctober 14-18 • Philadelphia, PAStrategic and Operational Challenges of Oncology and Immuno-Oncology Drug DevelopmentOctober 14-15 • Philadelphia, PAImmunogenicity & Bioassay SummitOctober 15-18 • Alexandria, VASYMPOSIUM: Immunology for BiotherapeuticsOctober 15 • Alexandria, VA
Immunogenicity Assessment & Clinical RelevanceOctober 16-17 • Alexandria, VAImmunogenicity Prediction & ControlOctober 17-18 • Alexandria, VAOptimizing Bioassays for BiologicsOctober 17-18 • Alexandria, VALeaders in Biobanking CongressOctober 30 - November 1 • Miami, FLSummit for Clinical Ops Executives (SCOPE)February 18-21 • Orlando, FLClinical Data Strategy and AnalyticsFebruary 19-20 • Orlando, FLProtocol Development, Global Site Selection, Feasibility and Site ManagementFebruary 19-20 • Orlando, FLAccessing and Generating RWDFebruary 19-20 • Orlando, FL Enrollment Planning and Patient RecruitmentFebruary 19-20 • Orlando, FLClinical Trial Forecasting, Budgeting and ContractingFebruary 19-20 • Orlando, FLImplementing Risk-Based Monitoring – Part 1February 19-20 • Orlando, FLMastering an Outsourcing StrategyFebruary 19-20 • Orlando, FLClinical Biomarkers Operations and InnovationFebruary 19-20 • Orlando, FL
Clinical Supply ManagementFebruary 19-20 • Orlando, FLSensors, Wearables and Digital Biomarkers in Clinical TrialsFebruary 19-20 • Orlando, FLMedical Device Clinical Trial Operations and RegulationsFebruary 19-20 • Orlando, FLClinical Technology and InnovationFebruary 20-21 • Orlando, FLManaging Outsourced Clinical TrialsFebruary 20-21 • Orlando, FLImplementing Risk-Based Monitoring – Part 2February 20-21 • Orlando, FLImproving Study Start-Up, Site Activation and Trial PerformanceFebruary 20-21 • Orlando, FLPatient Engagement, Enrollment and Retention through Communities and TechnologyFebruary 20-21 • Orlando, FLArtificial Intelligence in Clinical ResearchFebruary 20-21 • Orlando, FLResource Management and Capacity Planning for Clinical TrialsFebruary 20-21 • Orlando, FL
Drug TargetsSERIES
Discovery on TargetSeptember 16-19 • Boston, MAEmerging Ubiquitin and Autophagy TargetsSeptember 17-18 • Boston, MAImmuno-Oncology: Emerging Targets and TherapeuticsSeptember 17-18 • Boston, MALead Generation StrategiesSeptember 17-18 • Boston, MAAntibodies Against Membrane Protein Targets – Part 1September 17-18 • Boston, MATargeting NASHSeptember 17-18 • Boston, MATarget Identification and ValidationSeptember 17-18 • Boston, MA
Antibody Forum – Part 1September 17-18 • Boston, MA RNA as a Drug TargetSeptember 18-19 • Boston, MAKinase Inhibitor DiscoverySeptember 18-19 • Boston, MAPROTACs and Targeted Protein DegradationSeptember 18-19 • Boston, MATargeting FibrosisSeptember 18-19 • Boston, MAAntibody Forum – Part 2September 18-19 • Boston, MAGPCR-Based Drug DiscoverySeptember 18-19 • Boston, MAAntibodies Against Membrane Protein Targets – Part 2September 18-19 • Boston, MA
Leaders in Biobanking CongressOctober 30 - November 1 • Miami, FLModulating the Tumour MicroenvironmentNovember 18-19 • Lisbon, PortugalEngineering AntibodiesNovember 20-21 • Lisbon, PortugalEngineering BispecificsNovember 21-22 • Lisbon, PortugalAgonist Immunotherapy TargetsNovember 21-22 • Lisbon, PortugalEngineering Next-Generation Cancer ImmunotherapiesJanuary 20-21 • San Diego, CALead and Candidate Selection for Therapeutic ProteinsJanuary 21-22 • San Diego, CA
September 2019 – February 2020 | 7 www.healthtech.com
Conferences by Series
Discovery on TargetSeptember 16-19 • Boston, MAEmerging Ubiquitin and Autophagy TargetsSeptember 17-18 • Boston, MAImmuno-Oncology: Emerging Targets and TherapeuticsSeptember 17-18 • Boston, MALead Generation StrategiesSeptember 17-18 • Boston, MA Antibodies Against Membrane Protein Targets – Part 1September 17-18 • Boston, MA Targeting NASHSeptember 17-18 • Boston, MATarget Identification and ValidationSeptember 17-18 • Boston, MAAntibody Forum – Part 1September 17-18 • Boston, MARNA as a Drug TargetSeptember 18-19 • Boston, MAKinase Inhibitor DiscoverySeptember 18-19 • Boston, MA PROTACs and Targeted Protein DegradationSeptember 18-19 • Boston, MATargeting FibrosisSeptember 18-19 • Boston, MA
Antibody Forum – Part 2September 18-19 • Boston, MAGPCR-Based Drug DiscoverySeptember 18-19 • Boston, MAAntibodies Against Membrane Protein Targets – Part 2September 18-19 • Boston, MASYMPOSIUM: Immunology for BiotherapeuticsOctober 15 • Alexandria, VAImmunogenicity Assessment & Clinical RelevanceOctober 16-17 • Alexandria, VAImmunogenicity Prediction & ControlOctober 17-18 • Alexandria, VAOptimisation & DevelopabilityNovember 18-19 • Lisbon, PortugalDisplay of BiologicsNovember 18-19 • Lisbon, PortugalNext-Generation Antibody-Drug ConjugatesNovember 18-19 • Lisbon, PortugalEngineering AntibodiesNovember 20-21 • Lisbon, PortugalWinning Strategies for CAR T, TIL and TCR TherapyNovember 20-21 • Lisbon, Portugal
Engineering BispecificsNovember 21-22 • Lisbon, PortugalNovel Targets for Cancer and Emerging Therapeutic AreasNovember 21-22 • Lisbon, Portugal Optimizing Biologics Formulation DevelopmentJanuary 20-21 • San Diego, CAEngineering Next-Generation Cancer ImmunotherapiesJanuary 20-21 • San Diego, CA Recombinant Protein TherapeuticsJanuary 20-21 • San Diego, CA Antibody-Drug ConjugatesJanuary 21-22 • San Diego, CALead and Candidate Selection for Therapeutic ProteinsJanuary 21-22 • San Diego, CAProtein Aggregation and Emerging Analytical ToolsJanuary 23-24 • San Diego, CABispecific Antibody TherapeuticsJanuary 23-24 • San Diego, CADeep Sequencing and Single Cell Analysis for Antibody DiscoveryJanuary 23-24 • San Diego, CA
Protein Aggregation & StabilityNovember 21-22 • Lisbon, Portugal Sensors Global SummitDecember 10-12 • San Diego, CASensors for Chemical and Biological DetectionDecember 10-11 • San Diego, CA
Connectivity and Data for Sensors: IoT, AI & moreDecember 12 • San Diego, CACharacterization of BiotherapeuticsJanuary 20-21 • San Diego, CA
Detection and Characterization of Particulates and ImpuritiesJanuary 21-22 • San Diego, CA Leveraging RWD for Clinical and Observational ResearchFebruary 20-21 • Orlando, FL
SERIESEmerging Ubiquitin and Autophagy TargetsSeptember 17-18 • Boston, MAImmuno-Oncology: Emerging Targets and TherapeuticsSeptember 17-18 • Boston, MARNA as a Drug TargetSeptember 18-19 • Boston, MAPROTACs and Targeted Protein DegradationSeptember 18-19 • Boston, MATargeting Innate Immunity CongressSeptember 23-25 • Cambridge, MA
Strategic and Operational Challenges of Oncology and Immuno-Oncology Drug DevelopmentOctober 14-15 • Philadelphia, PAModulating the Tumour MicroenvironmentNovember 18-19 • Lisbon, PortugalNext-Generation Antibody-Drug ConjugatesNovember 18-19 • Lisbon, PortugalOptimising Expression PlatformsNovember 20-21 • Lisbon, PortugalEngineering BispecificsNovember 21-22 • Lisbon, Portugal
Engineering Next-Generation Cancer ImmunotherapiesJanuary 20-21 • San Diego, CARecombinant Protein TherapeuticsJanuary 20-21 • San Diego, CAVector Design and Development for Gene and Cell TherapiesJanuary 20-21 • San Diego, CAAntibody-Drug ConjugatesJanuary 21-22 • San Diego, CABispecific Antibody TherapeuticsJanuary 23-24 • San Diego, CACell Therapy Analytics and ManufacturingJanuary 23-24 • San Diego, CA
8 | Cambridge Healthtech Institute
Emerging Ubiquitin and Autophagy TargetsSeptember 17-18 • Boston, MA Lead Generation StrategiesSeptember 17-18 • Boston, MAAntibodies Against Membrane Protein Targets – Part 1September 17-18 • Boston, MATarget Identification and ValidationSeptember 17-18 • Boston, MARNA as a Drug TargetSeptember 18-19 • Boston, MAPROTACs and Targeted Protein DegradationSeptember 18-19 • Boston, MAAntibody Forum – Part 2September 18-19 • Boston, MAGPCR-Based Drug DiscoverySeptember 18-19 • Boston, MAAntibodies Against Membrane Protein Targets – Part 2September 18-19 • Boston, MALeaders in Biobanking CongressOctober 30 - November 1 • Miami, FLOptimisation & DevelopabilityNovember 18-19 • Lisbon, Portugal
Analytical Characterisation of BiotherapeuticsNovember 20-21 • Lisbon, PortugalEngineering AntibodiesNovember 20-21 • Lisbon, PortugalProtein Aggregation & StabilityNovember 21-22 • Lisbon, PortugalProtein Purification TechnologiesNovember 21-22 • Lisbon, PortugalPepTalk- The Protein Science WeekJanuary 20-24 • San Diego, CAOptimizing Biologics Formulation DevelopmentJanuary 20-21 • San Diego, CAVector Design and Development for Gene and Cell TherapiesJanuary 20-21 • San Diego, CACharacterization of BiotherapeuticsJanuary 20-21 • San Diego, CALyophilization and Emerging Drying TechnologiesJanuary 21-22 • San Diego, CAProtein Purification & RecoveryJanuary 21-22 • San Diego, CALead and Candidate Selection for Therapeutic ProteinsJanuary 21-22 • San Diego, CA
Gene Therapy Analytics and ManufacturingJanuary 21-22 • San Diego, CADetection and Characterization of Particulates and ImpuritiesJanuary 21-22 • San Diego, CAHigher-Throughput Protein Production & CharacterizationJanuary 23-24 • San Diego, CAProtein Aggregation and Emerging Analytical ToolsJanuary 23-24 • San Diego, CADeep Sequencing and Single Cell Analysis for Antibody DiscoveryJanuary 23-24 • San Diego, CACell Therapy Analytics and ManufacturingJanuary 23-24 • San Diego, CASensors, Wearables and Digital Biomarkers in Clinical TrialsFebruary 19-20 • Orlando, FLMedical Device Clinical Trial Operations and RegulationsFebruary 19-20 • Orlando, FL
Target Identification and ValidationSeptember 17-18 • Boston, MAAntibody Forum – Part 1September 17-18 • Boston, MASummit for Clinical Ops Executives EuropeSeptember 17-19 • Barcelona, SpainAnalytics-Driven Feasibility, Site Selection and Study ActivationSeptember 17-18 • Barcelona, SpainPatient-Centric Enrollment Planning and EngagementSeptember 17-18 • Barcelona, SpainRisk-Based Monitoring EuropeSeptember 17-18 • Barcelona, SpainDigitalization of Clinical TrialsSeptember 17-18 • Barcelona, Spain
Budgeting, Resource Management, and Outsourcing for Clinical TrialsSeptember 17-18 • Barcelona, SpainExecutive Decision MakingOctober 14-18 • Philadelphia, PAPortfolio ManagementOctober 17-18 • Philadelphia, PAAI World Conference & ExpoOctober 23-25 • Boston, MAOptimisation & DevelopabilityNovember 18-19 • Lisbon, PortugalEngineering AntibodiesNovember 20-21 • Lisbon, Portugal Protein Aggregation & StabilityNovember 21-22 • Lisbon, Portugal Lead and Candidate Selection for Therapeutic ProteinsJanuary 21-22 • San Diego, CA
Deep Sequencing and Single Cell Analysis for Antibody DiscoveryJanuary 23-24 • San Diego, CASummit for Clinical Ops Executives (SCOPE)February 18-21 • Orlando, FLClinical Data Strategy and AnalyticsFebruary 19-20 • Orlando, FLSensors, Wearables and Digital Biomarkers in Clinical TrialsFebruary 19-20 • Orlando, FLClinical Technology and InnovationFebruary 20-21 • Orlando, FLArtificial Intelligence in Clinical ResearchFebruary 20-21 • Orlando, FL
Conferences by Series
Target Identification and ValidationSeptember 17-18 • Boston, MACell Line and Systems EngineeringNovember 18-19 • Lisbon, Portugal
Clinical Biomarkers Operations and InnovationFebruary 19-20 • Orlando, FL
Clinical Biospecimens Technology and OutsourcingFebruary 20-21 • Orlando, FL
September 2019 – February 2020 | 9 www.healthtech.com
Conferences by Date with DetailDiscovery on TargetSeptember 16-19, 2019 • Boston, MAThe 17th Annual Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, will convene over 1,300 drug discovery professionals in Boston, MA, on September 16-19, 2019. This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules. Delegates can customize their experience at the event by choos-ing from 14 conference programs, plus focused training seminars, compre-hensive short courses, moderated roundtables and networking functions to meet their own research needs and those of their organizations.DiscoveryOnTarget.com
Summit for Clinical Ops Executives EuropeSeptember 17-18, 2019 • Barcelona, SpainBuilding on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five con-ference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials. Topics to be discussed include protocol development, global site selection, feasibility, site management, patient engagement, enrollment planning, patient recruitment, patient retention, improving site-study activation and performance, functional/full-service outsourcing and partnerships, new regulations and guidelines, Risk-Based Monitoring (RBM), clinical technology, big data and analytics, Real-World Data (RWD), Artificial Intelligence (AI), resource management, trial forecasting, and improving overall quality and speed of clinical trials.ScopeSummitEurope.com
Targeting Innate Immunity CongressSeptember 23-25, 2019 • Cambridge, MARecognizing the importance of the relatively untapped innate immune system as a possible tool for therapeutic intervention, the Inaugural Targeting Innate Immunity Congress will convene all thought leaders including industry experts, academic researchers and clinicians to deepen our understanding of innate immunity and learn to harness its power for effective immunotherapies. This two-day congress focuses on the current landscape and novel advances in the field of innate immunotherapy, such as natural killer cells, macrophages and dendritic cells. Be part of the conversation on mechanisms of action of innate cells, effective modulat-ing strategies, the impact of tumor microenvironment and many more. Share new insights and learn from others to maximize the success of your strategies in an intimate setting created for participants to exchange in-novative ideas, foster meaningful collaborations and keep up-to-date with new discoveries in the innate immunity research community.InnateImmunityCongress.com
Executive Decision MakingOctober 14-18, 2019 • Philadelphia, PACambridge Healthtech Institute’s annual executive forum brings together R&D executives from the biopharma community to share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting, resource management, and immuno-oncology drug development. Attendees will gain strategic insights and proven tools, methods, and perspectives from a variety of leaders at the intersection of science, business, and operations.ExecutiveDecisionMaking.com
Immunogenicity & Bioassay SummitOctober 15-18, 2019 • Alexandria, VANow in its 11th year, CHI’s Immunogenicity & Bioassay Summit will exam-ine the challenges currently facing the industry and will provide NEW case studies, NEW perspectives and NEW approaches. You will hear from the industry, academia and the regulatory authorities. This year we present 3 Conference Programs, a Symposium, Training Seminar and many short courses for in-depth study, as well as interactive breakout discussions for sharing of experiences and ideas, and excellent networking opportunities.ImmunogenicitySummit.com
AI World Conference & ExpoOctober 23-25, 2019 • Boston, MAAI World 2019 features a significant expansion of content coverage, includ-ing the addition of pre-conference half-day seminars on topics such as AI in Customer Analytics, AI & Cybersecurity, and AI for Business Leaders. Our main conference program has been expanded to include focused tracks covering a multitude of industries and technology topics such as Financial Services, AI in Healthcare, AI in Pharma, AI in Retail and eCom-merce, AI in Energy, AI in Manufacturing, Emerging AI Research, and much more. In addition, over three days you’ll have 15+ hours to network with industry leaders and your peers, including our popular birds of a feather networking reception, and you will gain access to our state-of-the-art mobile app which enables attendees to schedule their own meetings throughout the conference.AIWorld.com
Leaders in Biobanking CongressOctober 30 - November 1, 2019 • Miami, FLCambridge Healthtech Institute’s Eleventh International Leaders in Biobanking Congress addresses biospecimen science, management, and applications, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research, leading to the goal of personal-ized medicine.BiobankingCongress.com
PEGS Europe: Protein & Antibody Engineering SummitNovember 18-22, 2019 • Lisbon, PortugalPEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2018, more than 1,100 delegates from 36 countries, including 70% from pharma and biotech organizations, convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering. PEGSummitEurope.com
Digital Healthcare Innovation Summit (DHIS)December 10, 2019 • Boston, MAThe Digital Healthcare Innovation Summit (DHIS) is an Unparalleled Annual Gathering of the Leading Innovators, Investors, Payers, Providers and Policymakers who are Driving the Digital Health Revolution.MolecularDXEurope.com
Sensors Global SummitDecember 10-12, 2019 • San Diego, CAEmerging technological innovations enabled by next generation sensors will define the landscape for the future commercialization of life chang-ing products. The exponential growth of the global sensors market and the demand for next generation integrated systems is expected to reach over $150 billion by 2025. Our international faculty of key industry and academic leaders will present the latest technological advancements of real-world applications within healthcare, manufacturing and emerging markets through our featured plenary talks, conference tracks, tutorials and roundtable discussions.SensorsGlobalSummit.com
10 | Cambridge Healthtech Institute
Conferences by Date with DetailPepTalk- The Protein Science WeekJanuary 20-24, 2020 • San Diego, CAHear from some of the most influential and thought-provoking speakers in the biotherapeutics industry. Gain insight into emerging strategies, the latest innovative technologies, and best practices to move your research to the next level. Network with international thought leaders, collaborate with your peers and build your network in a friendly atmosphere.CHI-PepTalk.com
Summit for Clinical Ops Executives (SCOPE)February 18-21, 2020 • Orlando, FLCelebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote ses-sions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, manage-ment and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibil-ity, Data Strategy and Analytics, Sensors and Wearables, Project Manage-ment, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Sup-ply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and an all new track on Medical Device Clinical Trial Operations and Regulations.ScopeSummit.com
LEAD GENERATION
LIFE SCIENCE
PROGRAMS
Cambridge Healthtech Institute’s
Healthtech.com/Lead-Gen
WebinarsWhitepapersMarket ResearcheBooksPodcasts
Content marketing designed to fill your pipeline with targeted leads!
Increase your Sales Revenue with
September 2019 – February 2020 | 11 www.healthtech.com
Connecting clients with core clinical research training solutions and resources.
CONNECTING LEARNING TO CLINICAL RESEARCH OUTCOMES
• Live & Web-Based Seminars • Custom Programs & Services• Publications & Job Aides BarnettInternational.com
Connecting clients with core clinical research training solutions and resources.
CONNECTING LEARNING TO CLINICAL RESEARCH OUTCOMES
• Live & Web-Based Seminars • Custom Programs & Services• Publications & Job Aides BarnettInternational.com
SC = Short Course | TS = Training Seminar
Discovery on TargetSeptember 16-19, 2019 • Boston, MASC1: Immunology BasicsSC2: Targeting of Ion Channels with Monoclonal Antibodies SC3: Selection, Screening and Engineering for Affinity ReagentsSC4: How to Best Utilize 3D Cells, Spheroids and PDX Models in OncologySC5: How to Best Utilize 3D Cells, Spheroids and PDX Models in OncologySC6: Biochemistry and Pharmacology of the Ubiquitin-Proteasome SystemSC8: GPCR Structure-Based Drug DiscoverySC9: Targeted Protein Degradation Using PROTACs, Molecular Glues and MoreTS1: Targeting GPCRs for Drug DiscoveryTS2: An In-Depth Introduction to Drug Metabolism and Applications to Discovery and
DevelopmentTS3: Introduction to Small Molecule Drug Discovery and DevelopmentTS4: Practical Phenotypic Screening
Targeting Innate Immunity CongressSeptember 24-25, 2019 • Cambridge, MA SC1: Gene Edited Cell-Based Therapies: Opportunities and ChallengesSC2: Understanding and Modulating Tumor Microenvironment for Immunotherapy
Immunogenicity & Bioassays SummitOctober 15-18, 2019 • Washington, DCSC1: Mechanism of Action and Risk Based Approach for Developing Neutralizing Antibody
AssaysSC2: Overcoming Drug Target Interference in ADA AssaysSC3: Validation of ADA Assays and Cut Point CalculationsSC4: Advice on Putting Together an Integrated Summary of ImmunogenicitySC5: Bioassay Quality by DesignTS1: An Introduction to Strategic Bioassay Design, Development, Analysis, Validation, and
Monitoring
Leaders in Biobanking CongressOctober 30 - November 1, 2019 • Miami, FLSC1: Research Electronic Data Capture (REDCap): A Crash Course on Building Web-Based
Data Collection FormsSC2: CAP Biorepository Accreditation Program: Overview and Lessons from the First Five
Years
PEGS Europe: Protein & Antibody Engineering SummitNovember 18-22, 2019 • Cambridge, MASC1: Advanced Introductory Course on Making Antibody Libraries in Phage and YeastSC2: The Tumour Microenvironment and Response to Cancer ImmunotherapySC3: Mutation and Selection Strategies Beyond Affinity OptimisationSC4: Surfactants in Biotherapeutics: Can’t Live with Them, Can’t Live without ThemSC5: Use and Troubleshooting of Eukaryotic Expression SystemsSC6: Selection, Screening and Engineering for Affinity ReagentsSC7: Protein Aggregation: Mechanism, Characterization and ConsequencesSC8: Advanced Analytical Technologies for Developability and Early Formulation
AssessmentsSC9: T Cell Therapies: Current Field, Challenges and Future DirectionsSC10: Engineering of Bispecific Antibodies and Multi-Specific Non-Antibody ScaffoldsTS6A: Antibody Deep Sequencing and Single Cell AnalysisTS7A: Intro to Bispecifics: History, Engineering, and ApplicationsTS6B: Genome Editing with CRISPR: Toward Novel Research, Translational and Clinical
ApplicationsTS7B: Rational Approaches to Biologics Formulation and Delivery
PepTalk: The Protein Science WeekJanuary 20-24, 2019 • San Diego, CASC1: Best Practices for Biotherapeutic Discovery and DevelopmentSC2: The Safety of Immunotherapy and ADCs: How to Mitigate Risk and Adverse EffectsSC3: Structure-Based Optimization of AntibodiesSC5: Protein Aggregation: Mechanisms, Characterization, and ConsequencesSC6: Assembling an Effective Toolbox of Expression Systems to Support Your Drug
Discovery EffortsSC6: Introduction to Host Cell Proteins: Analysis, Characterization, Risks, and RequirementsTS8A: Protein Aggregation and Formulation OptimizationTS9A: Introduction to Antibody EngineeringTS8B: Next-Generation Approaches to Antibody Screening and DiscoveryTS9B: GMP and Validation Requirements for Biologics Processes – Phase I through to
Commercial Manufacturing
Short Courses and Training Seminars
CHI is a division of Cambridge Innovation Institute
CHI
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-CON, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target.
About Cambridge Healthtech InstituteYour Life Science Network
healthtech.com250 First Avenue, Suite 300
Needham, Massachusetts 02494
USA Phone: 781.972.5400
Additional divisions of CHI include
healthtechpublishing.com
insightpharmareports.com
barnettinternational.com
